NELSON MULLINS RILEY & SCARBOROUGH

Lobbying for PHRMA · Pharmaceutical

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry

Medicare/Medicaid

Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry, Medicare Part B

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.